Decreases in APOE in patients with early-stage CRC (0.58-fold) and late-stage CRC (0.68-fold) in this study indicated that APOE may play roles in suppressing tumor activity, which is consistent with previous studies. This evidence concerns the gene APOE and neoplasm.